{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:31Z","timestamp":1791267151700,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000262","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005242","name":"University of Montreal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcjo.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:12:00Z","timestamp":1778245920000},"page":"1088-1096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety of insulin eye drops in the treatment of open angle glaucoma: a randomized phase I clinical trial"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2132-0842","authenticated-orcid":false,"given":"Jiaru","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Nassrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Quan-Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2817-8831","authenticated-orcid":false,"given":"Lina","family":"El Mounji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0627-3662","authenticated-orcid":false,"given":"Georges","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Agoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-7360","authenticated-orcid":false,"given":"Jeffrey L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Di Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8674-6994","authenticated-orcid":false,"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2026.04.004_bib0001","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3129\/i09.080","article-title":"Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye","volume":"44","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0002","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0079-6123(08)01126-6","article-title":"Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation","volume":"173","author":"Schwartz","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12433","article-title":"Deciphering brain insulin receptor and insulin-like growth factor 1 receptor signalling","volume":"28","author":"Kleinridders","year":"2016","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0004","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/brain\/awy142","article-title":"Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury","volume":"141","author":"Agostinone","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0005","doi-asserted-by":"crossref","first-page":"eadl5722","DOI":"10.1126\/sciadv.adl5722","article-title":"Insulin restores retinal ganglion cell functional connectivity and promotes visual recovery in glaucoma","volume":"10","author":"El Hajji","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/jop.1994.10.101","article-title":"Toxicity of insulin administered chronically to human eye in vivo","volume":"10","author":"Bartlett","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0007","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/ICO.0000000000001297","article-title":"Use of topical insulin to treat refractory neurotrophic corneal ulcers","volume":"36","author":"Wang","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0008","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/jop.1994.10.683","article-title":"Insulin administration to the eyes of normoglycemic human volunteers","volume":"10","author":"Bartlett","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0009","first-page":"208","article-title":"Topical insulin for healing of diabetic epithelial defects?: a retrospective review of corneal debridement during vitreoretinal surgery in Malaysian patients","volume":"68","author":"Bastion","year":"2013","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0010","first-page":"418","article-title":"Randomized controlled trial of topical insulin for healing corneal epithelial defects induced during vitreoretinal surgery in diabetics","volume":"6","author":"Fai","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0011","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICL.0000000000000623","article-title":"Short-term results of trial of topical insulin for treatment of dry eyes in diabetics","volume":"46","author":"Aniah Azmi","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0012","unstructured":"insulin injection. Humulin R vials. Accessed April 15, 2025. https:\/\/pi.lilly.com\/ca\/humulin-r-ca-pmi-vial.pdf"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0013","unstructured":"ENTUZITYTM KwikPen\u00ae. Accessed April 15, 2025. https:\/\/pi.lilly.com\/ca\/entuzity-ca-pm.pdf"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0014","first-page":"71","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human participants","volume":"333","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/02713683.2025.2456784","article-title":"The performance of topical insulin in persistent corneal epithelial defects and persistent corneal ulcers\u2014A case series","volume":"50","author":"Mester","year":"2025","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0016","first-page":"797","article-title":"Accumulation of topically applied porcine insulin in the retina and optic nerve in normal and diabetic rats","volume":"43","author":"Koevary","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0017","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1529-1839(04)70038-X","article-title":"Pharmacokinetics of insulin uptake by ocular tissues and the role of cerebrospinal fluid in optic nerve insulin accumulation following topical insulin application","volume":"75","author":"Koevary","year":"2004","journal-title":"Optometry"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0018","series-title":"WHO International Standard Insulin Porcine NIBSC code: 83\/515 instructions for use (version 3.0, dated March 4, 2008)","year":"2008"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0019","first-page":"667","article-title":"Topical insulin protects against retinal ganglion cell loss in nonhuman primate model of experimental glaucoma","volume":"65","author":"Chaudhary","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108754","article-title":"Age-related changes in the rhesus macaque eye","volume":"212","author":"Lin","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0022","article-title":"A phase 1 randomized trial of topical insulin for glaucoma: safety and efficacy outcomes","volume":"6","author":"Saludares","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0023","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/ceo.13818","article-title":"Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial","volume":"48","author":"Hui","year":"2020","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","article-title":"Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial","volume":"140","author":"De Moraes","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajo.2021.11.002","article-title":"Corrigendum to phase 1b randomized controlled study of short course topical recombinant human nerve growth factor (rhNGF) for neuroenhancement in glaucoma: safety, tolerability, and efficacy measure outcomes","volume":"234","author":"Beykin","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100298","article-title":"Phase I NT-501 ciliary neurotrophic factor implant trial for primary open-angle glaucoma: safety, neuroprotection, and neuroenhancement","volume":"3","author":"Goldberg","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0027","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12035-012-8339-9","article-title":"Insulin in the brain: sources, localization and functions","volume":"47","author":"Ghasemi","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0028","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1016\/S0021-9258(17)37214-9","article-title":"Insulin gene expression and insulin synthesis in mammalian neuronal cells","volume":"269","author":"Devaskar","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0029","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/272827a0","article-title":"Insulin receptors are widely distributed in the central nervous system of the rat","volume":"272","author":"Havrankova","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1350-9462(03)00035-1","article-title":"Functions of insulin and insulin receptor signaling in retina: possible implications for diabetic retinopathy","volume":"22","author":"Reiter","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0031","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnins.2017.00232","article-title":"Nicotinamide and WLDS act together to prevent neurodegeneration in glaucoma","volume":"11","author":"Williams","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0032","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1073\/pnas.0906678106","article-title":"Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma","volume":"106","author":"Lambiase","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0033","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1038\/s41598-020-60427-2","article-title":"Topical recombinant human nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration","volume":"10","author":"Guo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0034","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.exer.2010.05.016","article-title":"Neurotrophic factor delivery as a protective treatment for glaucoma","volume":"93","author":"Johnson","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jcjo.2026.04.004_bib0035","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ijms17091584","article-title":"Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration","volume":"17","author":"Kimura","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226001511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226001511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:31:17Z","timestamp":1788982277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418226001511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0008418226001511"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.04.004","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of insulin eye drops in the treatment of open angle glaucoma: a randomized phase I clinical trial","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}